Table 3. Amino acid sites under positive selection in gp120 V3, C3 and C4 regions of HIV-1 clade C variants from patients at different disease stages.
Mean dN/dS ratio | |||||
Region | Position in HXB2 | Position in JR-FL | ES | CS | LS |
V3 | 300 | 297 | 3.056±0.699 | 3.056±0.690 | 4.676+1.223 |
309 | 306 | <1 | 3.019±0.718 | 4.676+1.226 | |
322 | 317 | 3.050±0.707 | 3.050±0.696 | <1 | |
C3 | 335 | 331 | 4.711±0.995 | 3.507±0.122 | <1 |
336 | 332 | 4.902±0.598 | 3.507±0.118 | 7.808±1.550 | |
337 | 333 | 4.864±0.703 | 3.505±0.138 | <1 | |
343 | 339 | 4.902±0.599 | 3.507±0.120 | <1 | |
344 | 340 | 4.901±0.600 | 3.507±0.118 | <1 | |
346 | 342 | 4.902±0.599 | 3.507±0.118 | <1 | |
347 | 343 | <1 | 3.505±0.143 | <1 | |
350 | 346 | 4.885±0.648 | 3.507±0.118 | <1 | |
352 | 348 | <1 | 3.494±0.220 | <1 | |
360 | 355 | 4.902±0.598 | 3.504±0.145 | <1 | |
362 | 357 | 4.902±0.598 | 3.507±0.118 | 7.807±1.552 | |
364 | 359 | 4.902±0.598 | 3.507±0.120 | 7.808±1.550 | |
C4 | 429 | 420 | 2.935±0.911 | 5.321±1.659 | 2.905±0.591 |
446 | 437 | <1 | <1 | 2.893±0.604 |
ES = Early disease Stage; CS = Chronic disease Stage; LS = Late disease Stage.